Return to homepagePandemic Pact

Genetic and Phenotypic Characterization of Sars-Cov-2 Viruses Isolated from Infected Patients.

Grant number: COVID0557

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $0

  • Funder

    ANID, MINCTCI - Chile

  • Principal Investigator

    Eugenio Ramírez Villalobos

  • Research Location

    Chile

  • Lead Research Institution

    INSTITUTO DE SALUD PUBLICA DE CHILE

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

4 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Early mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants in Chile.

Reduced neutralization against Delta, Gamma, Mu, and Omicron BA.1 variants of SARS-CoV-2 from previous non-Omicron infection.

Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.

Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients.